Want to see MTLS full AI Analyst Report?
MTLS Stock Chart & Stats
$6.67
-$0.10(-1.53%)
At close: 4:00 PM EDT
$6.67
-$0.10(-1.53%)
Day’s Range― - ―
52-Week Range$4.78 - $8.82
Previous CloseN/A
Volume24.86K
Average Volume (3M)214.94K
Market Cap
$478.74M
Enterprise Value$348.44M
Total Cash (Recent Filing)$133.68M
Total Debt (Recent Filing)$59.50M
Price to Earnings (P/E)31.0
Beta1.37
Next Earnings
Oct 28, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.23
Shares Outstanding59,067,184
10 Day Avg. Volume211,187
30 Day Avg. Volume214,944
Financial Highlights & Ratios
PEG Ratio-0.84
Price to Book (P/B)1.09
Price to Sales (P/S)1.09
P/FCF Ratio30.53
Enterprise Value/Market Cap0.73
Enterprise Value/Revenue1.27
Enterprise Value/Gross Profit2.21
Enterprise Value/Ebitda11.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.18
Revenue Forecast (FY)$276.09M
Bulls Say, Bears Say
Bulls Say
Medical Segment StrengthMedical is becoming a stronger growth and profitability engine, supported by double-digit revenue expansion and high segment margins. Its patient-specific solutions, device relationships, and clinical workflow exposure can deepen customer integration and support durable adoption over the next several quarters.
Net Cash And Improving ProfitabilityA net cash position and stronger operating cash generation give Materialise financial flexibility to fund research, product development, and targeted growth initiatives. The raised adjusted EBIT outlook also indicates improving operating leverage, strengthening resilience and internal funding capacity.
Portfolio Refocus And Software ExpansionEmbedding workflow software with HP printers can broaden distribution and place Materialise tools at the entry point of new additive installations. Combined with CO-AM expansion and divestments of non-core activities, this supports a more focused platform model with recurring potential.
Bears Say
Software Revenue And Transition PressureSoftware is strategically important, yet declining revenue and longer customer decision cycles can delay growth and weaken near-term operating leverage. The subscription transition may ultimately improve recurring revenue quality, but ongoing investment and conversion pressure can restrain margins during the adjustment period.
Manufacturing Near BreakevenManufacturing growth is not yet translating into reliable segment profitability, leaving consolidated earnings partly dependent on Medical and Software execution. Continued weakness in prototyping demand and near-breakeven margins could limit operating leverage and make returns less consistent.
Volatile Free Cash Flow ConversionAlthough recent cash generation improved, historically uneven free cash flow and only moderate conversion from net income indicate that working capital or investment needs can materially affect liquidity outcomes. This reduces the predictability of internally funded growth and shareholder returns.
Materialise News
MTLS FAQ
What was Materialise NV’s price range in the past 12 months?
Materialise NV lowest stock price was $4.78 and its highest was $8.82 in the past 12 months.
What is Materialise NV’s market cap?
Materialise NV’s market cap is $478.74M.
When is Materialise NV’s upcoming earnings report date?
Materialise NV’s upcoming earnings report date is Oct 28, 2026 which is in 8 days.
How were Materialise NV’s earnings last quarter?
Materialise NV released its earnings results on Aug 27, 2026. The company reported $0.067 earnings per share for the quarter, beating the consensus estimate of $0.045 by $0.022.
Is Materialise NV overvalued?
According to Wall Street analysts Materialise NV’s price is currently Overvalued.
Does Materialise NV pay dividends?
Materialise NV does not currently pay dividends.
What is Materialise NV’s EPS estimate?
Materialise NV’s EPS estimate is 0.02.
How many shares outstanding does Materialise NV have?
Materialise NV has 59,067,184 shares outstanding.
What happened to Materialise NV’s price movement after its last earnings report?
Materialise NV reported an EPS of $0.067 in its last earnings report, beating expectations of $0.045. Following the earnings report the stock price went up 11.244%.
Which hedge fund is a major shareholder of Materialise NV?
Currently, no hedge funds are holding shares in MTLS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Materialise Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
MTLS Sentiment 100%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Decreased
By 24.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 5.2%
Last 30 Days ▼ 5.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.63%
12-Months-Change
Fundamentals
Return on Equity
5.40%
Trailing 12-Months
Asset Growth
0.60%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Materialise NV
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
MTLS Company Deck
MTLS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive picture: healthy consolidated revenue growth (+8% Q2), clear margin and profitability improvements (adjusted EBITDA +16%, adjusted EBIT expansion), strong cash generation and net cash position, and strategic product and portfolio actions (CO-AM launches, Replasia investment, divestments) that position the company for scalable growth. Offsetting risks include a modest decline in Software revenue and near-term seasonality/costs (asset impairment, working capital increase), and ongoing weakness in certain Manufacturing subsegments (prototyping demand). On balance, the operational and financial momentum and the upgrade to adjusted EBIT guidance outweigh the contained headwinds reported.View all MTLS earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
0.11% Mutual Funds
9.18% Other Institutional Investors
89.97% Public Companies and
Individual Investors